Cargando…
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
OBJECTIVE: Wnt/β-catenin signaling is related to the pathogenesis of several diseases. Sclerostin is an inhibitor of Wnt/β-catenin signaling. However, there are few data regarding the sclerostin levels and vascular disease. Our aim was to examine the relationship between serum sclerostin and atheros...
Autores principales: | Morales-Santana, Sonia, García-Fontana, Beatriz, García-Martín, Antonia, Rozas-Moreno, Pedro, García-Salcedo, José Antonio, Reyes-García, Rebeca, Muñoz-Torres, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661830/ https://www.ncbi.nlm.nih.gov/pubmed/23288857 http://dx.doi.org/10.2337/dc12-1691 |
Ejemplares similares
-
Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018) -
Relationship between Proinflammatory and Antioxidant Proteins with the Severity of Cardiovascular Disease in Type 2 Diabetes Mellitus
por: García-Fontana, Beatriz, et al.
Publicado: (2015) -
Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
por: Garcia-Martín, Antonia, et al.
Publicado: (2014) -
Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
por: Sanabria-de la Torre, Raquel, et al.
Publicado: (2022) -
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
por: González-Salvatierra, Sheila, et al.
Publicado: (2023)